Literature DB >> 25144137

Replication characteristics of infectious laryngotracheitis virus in the respiratory and conjunctival mucosa.

Vishwanatha R A P Reddy1, Lennert Steukers, Yewei Li, Walter Fuchs, Alain Vanderplasschen, Hans J Nauwynck.   

Abstract

Avian infectious laryngotracheitis virus (ILTV) is an alphaherpesvirus of poultry that is spread worldwide. ILTV enters its host via the respiratory tract and the eyes. Although ILTV has been known for a long time, the replication characteristics of the virus in the respiratory and conjunctival mucosa are still poorly studied. To study these characteristics, two in vitro explant models were developed. Light microscopy and fluorescent terminal deoxynucleotidyl transferase dUTP nick end-labelling staining were used to evaluate the viability of mucosal explants, which were found to be viable up to the end of the experiment at 96 h of cultivation. The tracheal and conjunctival mucosal explants were inoculated with ILTV and collected at 0, 24, 48 and 72 h post inoculation (p.i.). ILTV spread in a plaque-wise manner in both mucosae. A reproducible quantitative analysis of this mucosal spread was evaluated by measuring plaque numbers, plaque latitude and invasion depth underneath the basement membrane. No major differences in plaque numbers were observed over time. Plaque latitude progressively increased to 70.4 ± 12.9 μm in the trachea and 97.8 ± 9.5 μm in the conjunctiva at 72 h p.i. The virus had difficulty crossing the basement membrane and was first observed only at 48 h p.i. The virus was observed at 72 h p.i. in 56% (trachea) and 74% (conjunctiva) of the plaques. Viability analysis of infected explants indicated that ILTV blocks apoptosis in infected cells of both mucosae but activates apoptosis in bystander cells.

Entities:  

Mesh:

Year:  2014        PMID: 25144137     DOI: 10.1080/03079457.2014.956285

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  6 in total

1.  Gallid Herpesvirus 1 Initiates Apoptosis in Uninfected Cells through Paracrine Repression of p53.

Authors:  Hai Li; Qi Gao; Yuhao Shao; Bangyao Sun; Fengjie Wang; Yangyang Qiao; Nana Wang; Shengwang Liu
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

2.  Growth kinetics and transmission potential of existing and emerging field strains of infectious laryngotracheitis virus.

Authors:  Sang-Won Lee; Carol A Hartley; Mauricio J C Coppo; Paola K Vaz; Alistair R Legione; José A Quinteros; Amir H Noormohammadi; Phillip F Markham; Glenn F Browning; Joanne M Devlin
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

3.  Productive replication of nephropathogenic infectious bronchitis virus in peripheral blood monocytic cells, a strategy for viral dissemination and kidney infection in chickens.

Authors:  Vishwanatha R A P Reddy; Ivan Trus; Lowiese M B Desmarets; Yewei Li; Sebastiaan Theuns; Hans J Nauwynck
Journal:  Vet Res       Date:  2016-07-13       Impact factor: 3.683

4.  Novel Insights into the Roles of Bcl-2 Homolog Nr-13 (vNr-13) Encoded by Herpesvirus of Turkeys in the Virus Replication Cycle, Mitochondrial Networks, and Apoptosis Inhibition.

Authors:  Vishwanatha R A P Reddy; Yashar Sadigh; Na Tang; Yongxiu Yao; Venugopal Nair
Journal:  J Virol       Date:  2020-05-04       Impact factor: 5.103

5.  Infectious laryngotracheitis: Etiology, epidemiology, pathobiology, and advances in diagnosis and control - a comprehensive review.

Authors:  Vasudevan Gowthaman; Sachin Kumar; Monika Koul; Urmil Dave; T R Gopala Krishna Murthy; Palanivelu Munuswamy; Ruchi Tiwari; Kumaragurubaran Karthik; Kuldeep Dhama; Izabela Michalak; Sunil K Joshi
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

6.  Replication characteristics of equine herpesvirus 1 and equine herpesvirus 3: comparative analysis using ex vivo tissue cultures.

Authors:  Haileleul Negussie; Yewei Li; Tesfaye Sisay Tessema; Hans J Nauwynck
Journal:  Vet Res       Date:  2016-01-15       Impact factor: 3.683

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.